Selenium replacement and outcome in critically ill septic patients.

ISRCTN ISRCTN20492006
DOI https://doi.org/10.1186/ISRCTN20492006
Secondary identifying numbers N0207104826
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
27/07/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr SM Mostafa
Scientific

Department of Anaesthesia
12th floor
Royal Liverpool University Hospital
Prescot Street
Liverpool
L7 8XP
United Kingdom

Study information

Study designSingle-centre prospective randomized double blind controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesTo measure outcome of selenium replacement in critically ill septic patients.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSigns and Symptoms: Sepsis
Intervention1. High selenium
2. Standard selenium
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Selenium
Primary outcome measureStudy of Selenium replacement and outcome in critically ill septic patients.
Secondary outcome measuresNot provided at time of registration
Overall study start date17/09/2001
Completion date31/10/2004

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants200, 100 in each group
Key inclusion criteriaCritically ill patients within the intensive therapy unit.
Key exclusion criteria1. Age <18yrs
2. Pregnant and lactating women
3. Patients not expected to survive >72 hrs
4. Refusal to participate
5. Chronic renal failure patient who is dialysis dependent
6. Severe gastrointestinal bleeding due to alcoholic liver disease
7. Patients known to have acquired AIDS, Hep B or C
8. Granulocyte count less than 1000/mm3 due to a cause other than sepsis
Date of first enrolment17/09/2001
Date of final enrolment31/10/2004

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Department of Anaesthesia
Liverpool
L7 8XP
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Hospital/treatment centre

Royal Liverpool and Broadgreen University Hospitals Trust (UK), No External Funding, NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/02/2007 Yes No